Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Change in Acquisitions & Divestments (2019 - 2025)

KalVista Pharmaceuticals' Change in Acquisitions & Divestments history spans 5 years, with the latest figure at $20.2 million for Q2 2025.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 30.56% to $20.2 million in Q2 2025 year-over-year; TTM through Apr 2025 was $122.8 million, a 17.0% increase, with the full-year FY2025 number at $122.5 million, up 16.74% from a year prior.
  • Change in Acquisitions & Divestments hit $20.2 million in Q2 2025 for KalVista Pharmaceuticals, down from $48.9 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for KALV hit a ceiling of $48.9 million in Q4 2024 and a floor of $11.6 million in Q1 2024.
  • Historically, Change in Acquisitions & Divestments has averaged $30.3 million across 3 years, with a median of $32.5 million in 2023.
  • The widest YoY moves for Change in Acquisitions & Divestments: up 50.24% in 2024, down 15.77% in 2024.
  • Tracing KALV's Change in Acquisitions & Divestments over 3 years: stood at $32.5 million in 2023, then soared by 50.24% to $48.9 million in 2024, then plummeted by 58.65% to $20.2 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for KALV at $20.2 million in Q2 2025, $48.9 million in Q4 2024, and $38.2 million in Q3 2024.